Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-22
2005-03-22
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S332000
Reexamination Certificate
active
06869959
ABSTRACT:
Compounds or salts thereof represented by the formula (I) wherein R1represents hydrogen atom, a C1-6alkyl group, a C1-6alkenyl group, or an acyl group, R2and R3represent hydrogen atom or a C1-6alkyl group, or adjacent R2and R3may combine to form 5- to 7-membered ring, R4represents hydrogen atom, hydroxyl group, a C1-6alkoxyl group, a C1-6alkyl group, HAr represents a heteroaryl-diyl group consisting of a 5-membered or 6-membered ring containing 1 to 3 hetero atoms, R5represents hydrogen atom or a C1-6alkyl group. The compounds or the salts thereof have retinoid-like physiological activities or controlling activity on physiological activities of retinoid.
REFERENCES:
patent: 3415834 (1968-12-01), Hoffmann et al.
patent: 3466373 (1969-09-01), Hoffmann et al.
patent: 3499898 (1970-03-01), Van Beberburg
patent: 4143151 (1979-03-01), Wagner et al.
patent: 4207330 (1980-06-01), Wagner et al.
patent: 4666915 (1987-05-01), Ozeki et al.
patent: 4785008 (1988-11-01), Coquelet et al.
patent: 4788195 (1988-11-01), Torley et al.
patent: 4868183 (1989-09-01), Kanai et al.
patent: 4876252 (1989-10-01), Torley et al.
patent: 5059598 (1991-10-01), Kanai et al.
patent: 5672710 (1997-09-01), Beard et al.
patent: 5728846 (1998-03-01), Vuligonda et al.
patent: 5739338 (1998-04-01), Beard et al.
patent: 5760276 (1998-06-01), Beard et al.
patent: 5766610 (1998-06-01), Bernardon
patent: 6015569 (2000-01-01), Bernardon
patent: 6093838 (2000-07-01), Vasudevan et al.
patent: 6156788 (2000-12-01), Bernardon
patent: 6162815 (2000-12-01), Bernardon
patent: 493528 (1970-07-01), None
patent: 2926644 (1980-01-01), None
patent: 144730 (1985-06-01), None
patent: 254259 (1988-01-01), None
patent: 679630 (1995-11-01), None
patent: 61-22047 (1986-01-01), None
patent: 61-76440 (1986-04-01), None
patent: 6126-7580 (1986-11-01), None
patent: 62123180 (1987-04-01), None
patent: 1-131169 (1989-05-01), None
patent: 3-127790 (1991-05-01), None
patent: 03204813 (1991-06-01), None
patent: 9-100270 (1997-04-01), None
patent: 9613478 (1996-05-01), None
patent: 9702244 (1997-01-01), None
patent: 9709297 (1997-03-01), None
patent: 9711061 (1997-03-01), None
patent: 9712853 (1997-04-01), None
patent: 9734869 (1997-09-01), None
patent: 9748672 (1997-12-01), None
patent: 9845242 (1998-10-01), None
patent: 9847854 (1998-10-01), None
patent: 9933821 (1999-07-01), None
English Language Abstract for JP 62 123180 A (Otsuka Pharmaceutical Factory Inc.), Jun. 4, 1987.
English Language Abstract for JP 03 204813 A (Otsuka Pharmaceutical Factory Inc.), Sep. 6, 1991.
K. Ozeki et al. “Studies on Antiallergy Agents. III” Chemical & Pharmaceutical Bulletin; vol. 37 (No. 7) pp. 1780-1787 (1989).
N. Finch et al. “Synthesis and Antihypertensive Activity of 5-amino-pyridinecarboxylic Acid Derivatives” Journal of Medicinal Chemistry; vol. 23 (No. 12) pp. 1405-1410 (1980).
Breaux et al., 18 J. Het. Chem. 183-84 (Jan. 1981).
Terashima et al., 43 (11) Chem. & Pharm. Bull. 2021-23 (Nov. 1995).
Gayo et al., 38 (2) Tett. Lett. 211-14 (Jan. 1997).
English Language Abstract of JP 61-22047, 1986.
English Language Abstract of JP 61-76440, 1986.
Journal of Medicinal Chemistry, 1988, vol. 31, No. 11, pp. 2182-2192.
Evans, R. M., Science, 240, pp. 889-895, 1988.
Petkovich, M., et al., Nature, 330, pp. 444-450, 1987.
Hashimoto, Y., Cell Structure and Function, 16, pp. 113-123, 1991.
Hashimoto, Y., et al., Biochemical Biophysical Research Communications, vol. 166, pp. 1300-1307, 1990.
English Language Abstract of WO 97/11061, 1997.
English Language Abstract of WO 98/45242, 1998.
Mangelsdorf, D. J. et al., Nature, vol. 345, pp. 224-229, 1990.
Mangelsdorf, D. J. et al., The Retinoids, 2nd Edition, Raven Press, Ltd., pp. 319-349, 1994.
Eyrolles, L., et al., Journal of Medicinal Chemistry, 37(10), pp. 1508-1517, 1994.
English Language Abstract of JP 9-100270, 1997.
English Language Abstract of JP 61-267580, 1986.
English Language Abstract of JP 1-131169, 1989.
English Language Abstract of WO 97/34869, 1997.
English Language Abstarct of WO 97/09297, 1997.
English Language Abstract of WO 97/02244, 1997.
English Language Abstract of WO 96/13478, 1996.
Institute of Medicinal Molecular Design Inc.
Raymond Richard L.
LandOfFree
Heterocyclic carboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic carboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic carboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3385412